Ivermectin for preventing and treating COVID‐19

Mostrar otras versiones (1)

BACKGROUND: Ivermectin, an antiparasitic agent, inhibits the replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) replication in early stages of infection....

Descripción completa

Detalles Bibliográficos
Autores principales: Popp, Maria, Reis, Stefanie, Schießer, Selina, Hausinger, Renate Ilona, Stegemann, Miriam, Metzendorf, Maria-Inti, Kranke, Peter, Meybohm, Patrick, Skoetz, Nicole, Weibel, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215332/
https://www.ncbi.nlm.nih.gov/pubmed/35726131
http://dx.doi.org/10.1002/14651858.CD015017.pub3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215332/
https://www.ncbi.nlm.nih.gov/pubmed/35726131
http://dx.doi.org/10.1002/14651858.CD015017.pub3

Ejemplares similares